Transdermal Diagnostics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $679K

  • Investors
  • 14

Transdermal Diagnostics General Information

Description

Developer of a wearable technology platform designed to improve the prevention, diagnosis, and management of chronic conditions, starting with diabetes. The company's technology allows needle-free and continuous monitoring of sugar levels for people with diabetes and prediabetes using affordable disposable patches, enabling users to gain biological insights and make informed decisions for a healthier lifestyle.

Contact Information

Website
www.transdermal-diagnostics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Science Creates Old Market
  • Midland Road
  • Bristol BS2 0NS
  • England, United Kingdom
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, Wearables & Quantified Self, HealthTech, Life Sciences
Corporate Office
  • Science Creates Old Market
  • Midland Road
  • Bristol BS2 0NS
  • England, United Kingdom

Transdermal Diagnostics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transdermal Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Seed Round 02-Mar-2026 $679K Completed Generating Revenue
7. Accelerator/Incubator 18-Sep-2025 Completed Generating Revenue
6. Seed Round 27-Mar-2024 Completed Generating Revenue
5. Grant 03-Feb-2023 Completed Generating Revenue
4. Seed Round 06-Sep-2022 Completed Generating Revenue
3. Grant 06-Sep-2022 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. University Spin-Out 16-Aug-2021 Completed Generating Revenue
To view Transdermal Diagnostics’s complete valuation and funding history, request access »

Transdermal Diagnostics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 463,600 $0.000136 $3.26 $3.26 1x $3.26 30.81%
To view Transdermal Diagnostics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Transdermal Diagnostics Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Transdermal Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202416247-D0 Skin contact sensor Pending 04-Nov-2024
GB-2702575-A Skin contact sensor Pending 04-Nov-2024
WO-2026093769-A1 Skin contact sensor Pending 04-Nov-2024
EP-4791281-A1 Method and sensor Pending 12-Oct-2023
GB-202315628-D0 Method and sensor Active 12-Oct-2023 A61B5/145
To view Transdermal Diagnostics’s complete patent history, request access »

Transdermal Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Transdermal Diagnostics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
The University of Edinburgh University
College Green Ventures Venture Capital Minority
Empirical Ventures Venture Capital Minority
West of England Local Enterprise Partnership Government
Bristol Private Equity Club Growth/Expansion Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Transdermal Diagnostics FAQs

  • When was Transdermal Diagnostics founded?

    Transdermal Diagnostics was founded in 2021.

  • Where is Transdermal Diagnostics headquartered?

    Transdermal Diagnostics is headquartered in Bristol, United Kingdom.

  • What is the size of Transdermal Diagnostics?

    Transdermal Diagnostics has 10 total employees.

  • What industry is Transdermal Diagnostics in?

    Transdermal Diagnostics’s primary industry is Monitoring Equipment.

  • Is Transdermal Diagnostics a private or public company?

    Transdermal Diagnostics is a Private company.

  • What is the current valuation of Transdermal Diagnostics?

    The current valuation of Transdermal Diagnostics is .

  • What is Transdermal Diagnostics’s current revenue?

    The current revenue for Transdermal Diagnostics is .

  • How much funding has Transdermal Diagnostics raised over time?

    Transdermal Diagnostics has raised $2.7M.

  • Who are Transdermal Diagnostics’s investors?

    The University of Edinburgh, College Green Ventures, Empirical Ventures, West of England Local Enterprise Partnership, and Bristol Private Equity Club are 5 of 14 investors who have invested in Transdermal Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process